Emmaus Life Sciences, Inc. EMMA
0.02 USD 0.00 (+0.00%)
Regular-session close
0.022 Day range 0.022
0.008 52-week range 0.0879
- YTD
- +76.92%
- 1 year
- +130.00%
News
gurufocus.com Emmaus Life Sciences Reports Quarterly Financial Results Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its
businesswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its…
businesswire.com Emmaus Life Sciences Advances Middle East Strategy with Real-World Evidence Initiatives and Expansion into Africa TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company focused on sickle cell disease (SCD), today announced the advancement of two…
